menobiotics® exists because women navigating menopause deserve products based on science that is honest, specific and designed for them — not one-size-fits-all wellness language applied to a life stage that deserves deep care, precision and a fuller understanding of its inherent complexity.
We believe the microbiome is a foundational layer of menopause health. We also believe the category needs better language and greater understanding of the individuality and biological reality of what women experience during menopause.
MENOBiOTiCS® is a registered trademark created to bring clarity, structure and meaning to a complex but increasingly important space.
menobiotics® is a registered trademark created to bring clarity, structure and meaning to a complex but highly important, yet underserved space.
menobiotics® creates a clearer category language for an area of women’s health that has largely remained underarticulated.
menobiotics® gives language to biotics positioned specifically for perimenopause, menopause and post-menopause.
The menopause category is growing quickly as awareness, discussion and commercial attention continue to expand. At the same time, the conversation is becoming more nuanced. Women want and deserve better information, more relevant choices and support that reflects the fact that menopause is not one fixed experience.
Symptoms, priorities and treatment preferences vary widely from woman to woman, and often change over time. Yet much of the category remains fragmented. Some brands focus narrowly on one symptom. Others rely on familiar hormone-adjacent language or trend-led ingredients. The result is often a category that feels repetitive, over-simplified and strategically vague.
The microbiome offers a more coherent biological framework. It is increasingly understood to interact with oestrogen metabolism and to have broader relevance across systems that matter during menopause.
A strong strategic position in a category that is becoming more important, more informed and more commercially significant.
Designed for perimenopause, menopause and post-menopause rather than stretched from general wellness.
A trademarked position that gives a name and commercial identity to an emerging white space.
Broad enough to support a wider menopause-support architecture over time.
Every woman who lives long enough will go through menopause, but no two experiences are the same.
For some, the most disruptive changes are hot flushes, sleep disturbance or mood shifts. For others, it is weight redistribution, digestive discomfort, brain fog, vaginal changes, loss of confidence or a broader sense that the body is no longer responding in familiar ways. Often, it is the layering of these changes that makes the experience so disruptive: not a single symptom to solve, but a shift in energy, resilience, comfort, cognition and self-trust that can feel gradual, unpredictable and deeply personal.
And for some women, menopause may not arrive with obvious symptoms at all, yet important underlying changes are still taking place across hormonal, metabolic, bone and microbial health.
Menopause does not need to feel dramatic to deserve attention, understanding and support.
Often, it is the layering of changes that makes the experience so disruptive: not a single symptom to solve, but a shift in energy, resilience, comfort, cognition and self-trust that can feel gradual, unpredictable and deeply personal.
For some women, menopause may not be marked by clear symptoms, yet important underlying changes are still unfolding across hormonal, cardiometabolic and bone health, with the microbiome increasingly understood as part of that wider picture.
Some want HRT. Some cannot use it.
Some do not want it. Many are looking for support that feels evidence-aware, specific and relevant to what they are actually experiencing.
The microbiome is not a trend layered onto this conversation. Research increasingly suggests that the decline in oestrogen during menopause is associated with changes in the gut microbiota, including reduced diversity and changes in the estrobolome, the collection of microbial genes involved in oestrogen metabolism.
These shifts may matter because they intersect with broader changes seen across menopause and ageing, including bone loss, cardiometabolic risk and inflammatory balance.
As the category grows, women need better frameworks, better language and better choices. They need support that recognises both the biology of menopause and the individuality of the journey.
That is where menobiotics® has value. It offers a name, a framework and a commercial language for a part of the menopause conversation that is genuinely important and still underdeveloped.
In a market where credibility and recognition matter, clarity can become a point of difference — and a basis for stronger consumer trust and longer-term loyalty.
More ownable than a standard probiotic or postbiotic proposition. More targeted than a generic menopause wellness concept. menobiotics® defines a specific territory and holds it with clarity.
The positioning makes space for the reality that menopause is different for every woman. That matters commercially because women are not looking for one narrow story.
The platform can support consumer, practitioner, pharmacy, retail or white-label directions depending on market, commercial model and partner ambition.
menobiotics® is framed as a commercial platform rather than a narrow single-product idea. That gives partners greater flexibility in how it is developed, positioned and brought to market.
Strong enough to begin with one focused product, yet broad enough to develop into a wider menopause-support portfolio over time, including gut, metabolic, bone and cognitive support.
A focused menopause-support line within supplements, functional food or wellness, built on strains and formulations selected for relevance to hormonal transition.
Integrated into an existing women’s health portfolio as a more defined and differentiated layer.
Developed with the right commercial partner under a licensing, acquisition or structured collaboration model.
menobiotics® is a registered trademark and defined commercial asset. Any commercial application would be structured formally, with the route shaped in collaboration with the chosen partner based on strategic fit and market opportunity.
Rights to use menobiotics® under agreed commercial terms, territories or product categories.
Transfer of the trademark and associated concept assets to the right buyer, including established brands seeking a stronger foothold in menopause-focused health.
Use of menobiotics® as the foundation for a new consumer-facing brand, product range or category platform developed by the right commercial partner.
A structured partnership that may include concept development, advisory input, co-development or commercial participation around the brand platform.
For partnership, licensing or acquisition conversations, get in touch.